The store will not work correctly when cookies are disabled.
2-((4-(2-amino-4-methoxypyrimidin-5-yl)-1H-imidazol-1-yl)methoxy)ethylacetate
ID: ALA4797883
PubChem CID: 162675767
Max Phase: Preclinical
Molecular Formula: C13H17N5O4
Molecular Weight: 307.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1nc(N)ncc1-c1cnn(COCCOC(C)=O)c1
Standard InChI: InChI=1S/C13H17N5O4/c1-9(19)22-4-3-21-8-18-7-10(5-16-18)11-6-15-13(14)17-12(11)20-2/h5-7H,3-4,8H2,1-2H3,(H2,14,15,17)
Standard InChI Key: LZTVOWBNXZISEH-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
12.7398 -1.9874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7387 -2.8148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4534 -3.2276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1699 -2.8142 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1670 -1.9838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4517 -1.5747 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0224 -3.2281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2690 -2.8920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7165 -3.5047 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1285 -4.2194 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9355 -4.0485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7924 -4.9729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9719 -5.0585 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6358 -5.8119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8153 -5.8975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4792 -6.6509 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8799 -1.5686 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0252 -1.5751 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0250 -0.7501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9637 -7.3187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6276 -8.0722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7842 -7.2331 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 7 2 0
2 7 1 0
10 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
5 17 1 0
1 18 1 0
18 19 1 0
16 20 1 0
20 21 1 0
20 22 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 307.31 | Molecular Weight (Monoisotopic): 307.1281 | AlogP: 0.47 | #Rotatable Bonds: 7 |
Polar Surface Area: 114.38 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.54 | CX LogP: 0.23 | CX LogD: 0.23 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.58 | Np Likeness Score: -0.86 |
References
1. Thames JE,Waters CD,Valle C,Bassetto M,Aouadi W,Martin B,Selisko B,Falat A,Coutard B,Brancale A,Canard B,Decroly E,Seley-Radtke KL. (2020) Synthesis and biological evaluation of novel flexible nucleoside analogues that inhibit flavivirus replication in vitro., 28 (22): [PMID:33128910] [10.1016/j.bmc.2020.115713] |